Trial Profile
A Randomized, Open, Two-Way Cross-Over, Single-Centre, Phase I Study to Assess the Counter Regulatory Response During Hypoglycaemia in Healthy Male Volunteers After a Single Oral Dose of AZD1656 Suspension in Comparison With Insulin Infusion
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AZD 1656 (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 20 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2008 New trial record.